Amylyx Pharmaceuticals, Inc.盘中异动早盘急速拉升5.45%

自选股智能写手07-10

北京时间2024年07月10日21时32分，Amylyx Pharmaceuticals, Inc.（AMLX.us）股票出现波动，股价急速拉升5.45%。截至发稿，该股报1.74美元/股，成交量74.0471万股，换手率1.09%，振幅2.73%。最近的财报数据显示，该股实现营业收入88.64百万美元，净利润-1.19亿美元，每股收益-1.75美元，毛利-28.08百万美元，市盈率-1.61倍。...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2450757890?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-07-10 21:32","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2450757890","market":"us","top_or_hot":-1,"title":"Amylyx Pharmaceuticals, Inc.盘中异动 早盘急速拉升5.45%","media":"自选股智能写手","content":"<div>\n<p>北京时间2024年07月10日21时32分，Amylyx Pharmaceuticals, Inc.（AMLX.us）股票出现波动，股价急速拉升5.45%。截至发稿，该股报1.74美元/股，成交量74.0471万股，换手率1.09%，振幅2.73%。最近的财报数据显示，该股实现营业收入88.64百万美元，净利润-1.19亿美元，每股收益-1.75美元，毛利-28.08百万美元，市盈率-1.61倍。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710213206941f5d2a&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Amylyx Pharmaceuticals, Inc.盘中异动 早盘急速拉升5.45%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAmylyx Pharmaceuticals, Inc.盘中异动 早盘急速拉升5.45%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-07-10 21:32 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710213206941f5d2a&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年07月10日21时32分，Amylyx Pharmaceuticals, Inc.（AMLX.us）股票出现波动，股价急速拉升5.45%。截至发稿，该股报1.74美元/股，成交量74.0471万股，换手率1.09%，振幅2.73%。最近的财报数据显示，该股实现营业收入88.64百万美元，净利润-1.19亿美元，每股收益-1.75美元，毛利-28.08百万美元，市盈率-1.61倍。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710213206941f5d2a&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AMLX","symbol_name":"Amylyx Pharmaceuticals, Inc.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710213206941f5d2a&s=b","article_id":"2450757890","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710213206941f5d2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2450757890","pubTimestamp":1720618326,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年07月10日21时32分，Amylyx Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.45%。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Virpax Pharmaceuticals, Inc.、Longeveron Inc.、Kazia Therapeutics Limited涨幅较大，Virpax Pharmaceuticals, Inc.、Soligenix, Inc.、Longeveron Inc.较为活跃，换手率分别为829.31%、530.83%、356.25%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Longeveron Inc.、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为48.28%、29.27%、19.01%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"AMLX":"Amylyx Pharmaceuticals, Inc.","BK4007":"制药"},"translate_title":"Amylyx Pharmaceuticals, Inc. surged 5.45% in early trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AMLX":1},"content_text":"北京时间2024年07月10日21时32分，Amylyx Pharmaceuticals, Inc.（AMLX.us）股票出现波动，股价急速拉升5.45%。截至发稿，该股报1.74美元/股，成交量74.0471万股，换手率1.09%，振幅2.73%。最近的财报数据显示，该股实现营业收入88.64百万美元，净利润-1.19亿美元，每股收益-1.75美元，毛利-28.08百万美元，市盈率-1.61倍。机构评级方面，在所有6家参与评级的机构中，17%的券商给予买入建议，83%的券商给予持有建议，无券商给予卖出建议。Amylyx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Virpax Pharmaceuticals, Inc.、Longeveron Inc.、Kazia Therapeutics Limited涨幅较大，Virpax Pharmaceuticals, Inc.、Soligenix, Inc.、Longeveron Inc.较为活跃，换手率分别为829.31%、530.83%、356.25%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Longeveron Inc.、180 Life Sciences Corp C/Wts 07/11/2025(To Pur Com)，振幅分别为48.28%、29.27%、19.01%。Amylyx Pharmaceuticals, Inc.公司简介：Amylyx Pharmaceuticals Inc是一家临床阶段的制药公司，致力于开发一种治疗肌萎缩性侧索硬化症和其他神经退行性疾病的新疗法。公司的唯一业务部门是研究和开发神经退行性疾病的治疗方法。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2450757890"}

Amylyx Pharmaceuticals, Inc.盘中异动 早盘急速拉升5.45%

精彩评论

Amylyx Pharmaceuticals, Inc.盘中异动早盘急速拉升5.45%